The Business Case for Immix Biopharma and CAR T-Cell Therapy for AL Amyloidosis
Harnessing the Power of Your Immune System Chimeric antigen receptor (CAR) T-cell therapy is a groundbreaking approach that utilizes the body’s own immune system to combat certain blood immune disorders. Immix Biopharma has leveraged this technology, amassing data on over 75 patients, and is now focusing its proprietary CAR T system on treating AL Amyloidosis. […]